Condition
Macular Edema Due to Type 2 Diabetes Mellitus
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Unknown2
Clinical Trials (2)
Showing 2 of 2 trials
NCT05759884Not ApplicableUnknownPrimary
Efficacy Analysis of Anti-VEGF Drugs Combined With Micropulse Laser in the Treatment of Diabetic Macular Edema
NCT05655117Not ApplicableUnknown
Application of Artificial Intelligence in Early Detection of Eye Complications in Diabetics
Showing all 2 trials